Treatment of Lateral Epicondylalgia With Shock Waves
Radial Shock Waves Versus Focal Shock Waves in the Treatment of Lateral Epicondylalgia
1 other identifier
interventional
50
1 country
1
Brief Summary
Lateral epicondylalgia (LET) is characterized by pain, decreased muscle strength of the wrist extensor muscles, and disability. Among the treatments proposed in the literature, both focal shockwave therapy and radial shockwave therapy have been considered effective in the management of this musculoskeletal disorder. The objective of this study is to compare the safety and effectiveness of these two shockwave applications on the signs and symptoms of subjects with lateral epicondylalgia. In this clinical trial, subjects will be evaluated for elbow pain using a Visual Analog Scale (VAS), grip strength using a handheld dynamometer, and degree of disability using the Patient-Rated Tennis Elbow Evaluation Questionnaire (PRTEE). A six-month follow-up will be performed. Patients will be randomly divided into three groups. The first group will receive radial shock waves (rESWT), the second group will receive focal shock waves (fESWT), and the third group, which will act as a control, will receive a placebo treatment with very low energy parameters according to the literature. Subjects will receive three sessions, one session per week.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
March 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 20, 2027
ExpectedMay 1, 2026
April 1, 2026
1.1 years
September 4, 2024
April 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Pain with Visual Analogue Scale (VAS)
The pain VAS is a unidimensional measure of pain intensity, used to record patients' pain progression. VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured where "0" on the far left is no pain and "10" on the far right is the worst pain possible.
Change from Baseline pain at 6 month
Secondary Outcomes (3)
Grip strength
Change from Baseline pain at 6 month
Patient Rated Tennis Elbow Evaluation (PRTEE)
Change from Baseline pain at 6 month
The Global Rating of Change (GROC)
Change from Baseline pain at 6 month
Study Arms (3)
Radial Shock Wave Treatment
EXPERIMENTALPatients assigned to this group will receive three sessions. During each session, 2000 pulses will be administered using a radial shock wave generator, with a pressure of 2.5 bars and a frequency of 8 Hz.
Focal Shock Wave Treatment
EXPERIMENTALPatients assigned to this group will receive three sessions. During each session, 2000 pulses will be delivered by a focal shock wave generator, with an energy flux density of 0.2 mJ/mm² and a frequency of 4 Hz.
Placebo Shock Waves
PLACEBO COMPARATORSubjects in this group will receive a placebo treatment with very low energy settings, designed to simulate therapy without offering real therapeutic effects. This group will receive 20 pulses per session, with an energy flux density of 0.08 mJ/mm².
Interventions
Subjects in this group will receive radial shock waves
Subjects in this group will receive focal shock waves
Subjects in this group will receive a shock waves placebo treatment with very low energy settings
Eligibility Criteria
You may qualify if:
- Pain in the lateral epicondyle \>3 months
- Pain when performing resisted grip
- Positive Cozen test
- Positive Maudsley test
You may not qualify if:
- Pregnancy
- Systemic diseases (Fibromyalgia, Diabetes, Arthritis)
- Local infection or Cancer
- Recent treatments (Physiotherapy, Corticosteroids)-
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro Investigación Fisioterapia y Dolor
Alcalá de Henares, Madrid, 28806, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 4, 2024
First Posted
September 19, 2024
Study Start
March 12, 2025
Primary Completion
April 20, 2026
Study Completion (Estimated)
June 20, 2027
Last Updated
May 1, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share